Aj. Sleight et al., CHARACTERIZATION OF RO-04-6790 AND RO-63-0563 - POTENT AND SELECTIVE ANTAGONISTS AT HUMAN AND RAT 5-HT6 RECEPTORS, British Journal of Pharmacology, 124(3), 1998, pp. 556-562
1 This study describes the in vitro characterization of two potent and
selective 5-HT6 receptor antagonists at the rat and human recombinant
5-HT6 receptor.2 In binding assays with [H-3]-LSD, 4-amino-N-(2,6 bis
-melhylamino-pyrimidin-4-yl)-benzene sulphonamide (Ro 04-6790) and 4-a
mino-N-(2,6 bis-methylamino-pyridin-4-yl)-benzene sulphonamide (Ro 63-
0563) had mean pK(i) values +/-s.e.mean at the rat 5-HT6 receptor of 7
.35+/-0.04 and 7.83+/-0.01, respectively and pK(i) values at the human
5-HT6 receptor of 7.26+/-0.06 and 7.91+/-0.02, respectively. 3 Both c
ompounds were found to be over 100 fold selective for the 5-HT6 recept
or compared to 23 (Ro 04-6790) and 69 (Ro 63-0563) other receptor bind
ing sites. 4 In functional studies, neither compound had any significa
nt effect on basal levels of cyclicAMP accumulation in Hela cells stab
ly expressing the human 5-HT6 receptor, suggesting that the compounds
are neither agonists nor inverse agonists at the 5-HT6 receptor. Howev
er, both Ro 04-6790 and Ro 63-0563 behaved as competitive antagonists
with mean +/-s.e.mean pA(2) values of 6.75 +/- 0.07 and 7.10 +/- 0.09,
respectively. 5 In rats habituated to observation cages, Ro 04-6790 p
roduced a behavioural syndrome similar to that seen following treatmen
t with antisense oligonucleotides designed to reduce the expression of
5-HT6 receptors. This behavioural syndrome consisted of stretching, y
awning and chewing. 6 Ro 04-6790 and Ro 63-0563 represent valuable pha
rmacological tools for the identification of 5-HT6 receptors in natura
l tissues and the study of their physiological function.